Summing up evidence: one answer is not always enough

Lancet
J LauC H Schmid

Abstract

Are meta-analyses the brave new world, or are the critics of such combined analyses right to say that the biases inherent in clinical trials make them uncombinable? Negative trials are often unreported, and hence can be missed by meta-analysts. And how much heterogeneity between trials is acceptable? A recent major criticism is that large randomised trials do not always agree with a prior meta-analysis. Neither individual trials nor meta-analyses, reporting as they do on population effects, tell how to treat the individual patient. Here we take a more rounded approach to meta-analyses, arguing that their strengths outweigh their weaknesses, although the latter must not be brushed aside.

References

Oct 1, 1992·British Heart Journal·E J Topol, R M Califf
Jan 11, 1992·BMJ : British Medical Journal·K L WoodsL F Smith
Jul 25, 1990·JAMA : the Journal of the American Medical Association·H S SacksD Pagano
Dec 1, 1987·Controlled Clinical Trials·K DickersinH Smith
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Oct 1, 1984·Statistics in Medicine·S YusufR Peto
Dec 1, 1982·American Journal of Public Health·H Morgenstern
Nov 30, 1995·The New England Journal of Medicine·UNKNOWN Early Breast Cancer Trialists' Collaborative Group
Nov 18, 1995·BMJ : British Medical Journal·P P Glasziou, L M Irwig
Feb 1, 1995·JAMA : the Journal of the American Medical Association·K F SchulzD G Altman
Jan 1, 1995·Journal of Clinical Epidemiology·C Anello, J L Fleiss
Jan 1, 1993·Statistical Methods in Medical Research·T C Chalmers, J Lau
May 22, 1993·BMJ : British Medical Journal·G D SmithT A Sheldon
Jan 22, 1996·Archives of Internal Medicine·J P IoannidisH S Sacks
Dec 27, 1995·JAMA : the Journal of the American Medical Association·D Moher, I Olkin
Dec 30, 1995·Statistics in Medicine·T C SmithA Thomas
Aug 28, 1996·JAMA : the Journal of the American Medical Association·C BeggD F Stroup
Sep 14, 1996·Lancet·J P Ioannidis, J Lau
Jun 30, 1996·Statistics in Medicine·T C Chalmers, J Lau
Sep 21, 1996·BMJ : British Medical Journal·S J SharpD G Altman
Oct 23, 1996·JAMA : the Journal of the American Medical Association·J C CappelleriJ Lau
Jul 10, 1997·The New England Journal of Medicine·R J LevineJ A Cutler
Nov 1, 1995·Journal of Evaluation in Clinical Practice·C D Naylor
Aug 21, 1997·The New England Journal of Medicine·J LeLorierF Derderian
Nov 22, 1997·Journal of Clinical Epidemiology·J P Ioannidis, J Lau
Feb 12, 1998·Annals of Internal Medicine·J LauC H Schmid

❮ Previous
Next ❯

Citations

Jan 29, 2002·Statistics in Medicine·Jesse A BerlinUNKNOWN Anti-Lymphocyte Antibody Induction Therapy Study Group
Dec 18, 2001·Statistics in Medicine·D B Petitti
Jul 12, 2002·Statistics in Medicine·Simon G Thompson, Julian P T Higgins
Jul 27, 2001·Statistics in Medicine·J P HigginsS G Thompson
Jul 27, 2006·Human Genetics·Elias ZintzarasJohn P A Ioannidis
Nov 21, 2007·Human Genetics·Fotini K Kavvoura, John P A Ioannidis
Dec 27, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Angebault, A Andremont
Jun 28, 2005·Diseases of the Colon and Rectum·Sanjay PurkayasthaAra Darzi
Jun 8, 2012·Journal of General Internal Medicine·Thomas A TrikalinosRongwei Fu
Feb 5, 2004·The Annals of Thoracic Surgery·Thanos AthanasiouBrian Glenville
Aug 9, 2005·Journal of Clinical Epidemiology·Norma TerrinJoseph Lau
Jan 26, 2002·Lancet·Murray M Pollack, Kantilal M Patel
Feb 7, 2002·Lancet·UNKNOWN Direct Thrombin Inhibitor Trialists' Collaborative Group
Feb 25, 2003·Lancet·John P A IoannidisDespina G Contopoulos-Ioannidis
Jan 16, 2004·Lancet·M AdjuikUNKNOWN International Artemisinin Study Group
Sep 24, 1998·Lancet·J P Ioannidis, J Lau
Aug 19, 2000·Hematology/oncology Clinics of North America·J P IoannidisJ Lau
Feb 27, 2001·Journal of Clinical Epidemiology·T A Trikalinos, J P Ioannidis
Oct 24, 2002·Journal of Clinical Epidemiology·Leonelo E BautistaLuz X Martínez
Sep 22, 1998·Journal of Clinical Epidemiology·J P Ioannidis, J Lau
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P A IoannidisN Pavlidis
Mar 22, 2002·The Lancet Oncology·J P Pignon, C Hill
May 3, 2003·Trends in Molecular Medicine·John P A Ioannidis
Aug 17, 2000·Clinical Transplantation·A SahotaR M Jindal
Jan 30, 2008·Nature Clinical Practice. Rheumatology·Axel Finckh, Martin R Tramèr
May 19, 1998·Nature Medicine·J P IoannidisJ J Goedert
Aug 8, 2001·Journal of Evaluation in Clinical Practice·A J SuttonD R Jones
Sep 3, 2003·Journal of General Internal Medicine·Bart van PinxterenPeter A L Bonis
Jan 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ramal MoonesingheJohn P A Ioannidis
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J P Ioannidis, J Lau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.